IRIS

Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry / De Luca, G; Cercek, M; Okkels Jensen, L; Bushljetikj, O; Calmac, L; Johnson, T; Gracida Blancas, M; Ganyukov, V; Wojakowski, W; von Birgelen, C; Ijsselmuiden, A; Tuccillo, B; Versaci, F; Ten Berg, J; Laine, M; Berkout, T; Casella, G; Kala, P; López Ledesma, B; Becerra, V; Padalino, R; Santucci, A; Carrillo, X; Scoccia, A; Amoroso, G; Lux, A; Kovarnik, T; Davlouros, P; Gabrielli, G; Flores Rios, X; Bakraceski, N; Levesque, S; Guiducci, V; Kidawa, M; Marinucci, L; Zilio, F; Galasso, G; Fabris, E; Menichelli, M; Manzo, S; Caiazzo, G; Moreu, J; Sanchis Forés, J; Donazzan, L; Vignali, L; Teles, R; Agostoni, P; Bosa Ojeda, F; Lehtola, H; Camacho-Freiere, S; Kraaijeveld, A; Antti, Y; Visconti, G; Lozano Martínez-Luengas, I; Scheller, B; Alexopulos, D; Moreno, R; Kedhi, E; Uccello, G; Faurie, B; Gutierrez Barrios, A; Scotto Di Uccio, F; Wilbert, B; Cortese, G; Dirksen, Mt; Parodi, G; Verdoia, M.. - In: BIOMÉDECINE & PHARMACOTHÉRAPIE. - ISSN 0753-3322. - (2021). [10.1016/j.biopha.2021.111469.]

Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry

Vignali L;
2021-01-01
2021
Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry / De Luca, G; Cercek, M; Okkels Jensen, L; Bushljetikj, O; Calmac, L; Johnson, T; Gracida Blancas, M; Ganyukov, V; Wojakowski, W; von Birgelen, C; Ijsselmuiden, A; Tuccillo, B; Versaci, F; Ten Berg, J; Laine, M; Berkout, T; Casella, G; Kala, P; López Ledesma, B; Becerra, V; Padalino, R; Santucci, A; Carrillo, X; Scoccia, A; Amoroso, G; Lux, A; Kovarnik, T; Davlouros, P; Gabrielli, G; Flores Rios, X; Bakraceski, N; Levesque, S; Guiducci, V; Kidawa, M; Marinucci, L; Zilio, F; Galasso, G; Fabris, E; Menichelli, M; Manzo, S; Caiazzo, G; Moreu, J; Sanchis Forés, J; Donazzan, L; Vignali, L; Teles, R; Agostoni, P; Bosa Ojeda, F; Lehtola, H; Camacho-Freiere, S; Kraaijeveld, A; Antti, Y; Visconti, G; Lozano Martínez-Luengas, I; Scheller, B; Alexopulos, D; Moreno, R; Kedhi, E; Uccello, G; Faurie, B; Gutierrez Barrios, A; Scotto Di Uccio, F; Wilbert, B; Cortese, G; Dirksen, Mt; Parodi, G; Verdoia, M.. - In: BIOMÉDECINE & PHARMACOTHÉRAPIE. - ISSN 0753-3322. - (2021). [10.1016/j.biopha.2021.111469.]
1.1 Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/3024818
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact